β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy

OBJECTIVE: To investigate CSF biomarkers in presymptomatic and symptomatic mutation carriers with hereditary cerebral hemorrhage with amyloidosis–Dutch type (HCHWA-D), a model for sporadic cerebral amyloid angiopathy, and to determine the earliest deposited form of β-amyloid (Aβ). METHODS: HCHWA-D m...

Full description

Saved in:

Bibliographic Details
Published in:	Neurology
Main Authors:	van Etten, Ellis S., Verbeek, Marcel M., van der Grond, Jeroen, Zielman, Ronald, van Rooden, Sanneke, van Zwet, Erik W., van Opstal, Anna M., Haan, Joost, Greenberg, Steven M., van Buchem, Mark A., Wermer, Marieke J.H., Terwindt, Gisela M.
Format:	Artigo
Language:	Inglês
Published:	Lippincott Williams & Wilkins 2017
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5224714/ https://ncbi.nlm.nih.gov/pubmed/27903811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003486
Tags:	Add Tag No Tags, Be the first to tag this record!

β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy

Similar Items